A new MHC locus that influences class I peptide presentation

Immunity

Volumn 7, Issue 5, 1997, Pages 641-651

  Simmons, William A ^h   Roopenian, Derry C ^b   Summerfield, Scott G ^c,f   Jones, Richard C ^c   Galocha, Begona ^d   Christianson, Gregory J ^b   Maika, Shanna D ^h   Zhou, Ming ^h   Gaskell, Simon J ^c   Bordoli, Robert S ^e   Ploegh, Hidde L ^d,g   Slaughter, Clive A ^h   Lindahl, Kirsten Fischer ^a   Hammer, Robert E ^h   Taurog, Joel D ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e MICROMASS UK LTD   (United Kingdom)

^f GLAXOSMITHKLINE   (United Kingdom)

^g HARVARD MEDICAL SCHOOL   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRITIUM;

ANIMAL CELL; ARTICLE; GENE LOCUS; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031462712     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80385-4     Document Type: Article

References (55)

1. r1 rat carries the HLA-DP-like (RT1.H) α and β genes of the DA strain. Immunogenetics 33, 202-205.
2. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J., and Townsend, A. (1995). Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25, 554-562.
3. de la Salle, H., Houssaint, E., Peyrat, M.-A., Arnold, D., Salamero, J., Pinczon, D., Stevanovic, S., Bausinger, H., Fricker, D., Gomard, E., et al. (1997). Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J. Immunol. 158, 4555-4563.
4. Deverson, E.V., Gow, I.R., Coadwell, J., Monaco, J.J., Butcher, G.W., and Howard, J.C. (1990). MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348, 738-741.
5. Fehling, H.J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U., and von Boehmer, H. (1994). MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237.
6. Groettrup, M., Soza, A., Kuckelkorn, U., and Kloetzel, P.-M. (1996). Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17, 429-435.
7. Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.-P., and Taurog, J.D. (1990). Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders. Cell 63, 1099-1112.
8. Hammond, C., and Helenius, A. (1995). Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7, 523-529.
9. Heemels, M.T., Schumacher, T.N., Wonigeit, K., and Ploegh, H.L. (1993). Peptide translocation by variants of the transporter associated with antigen processing. Science 262, 2059-2063.
10. Heemels, M.-T., and Ploegh, H.L. (1994). Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1, 775-784.
11. Heemels, M.-T., and Ploegh, H. (1995). Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64, 463-491.
12. Joly, E., Deverson, E.V., Coadwell, J.W., Gunther, E., Howard, J.C., and Butcher, G.W. (1994). The distribution of Tap2 alleles among laboratory rat RT1 haplotypes. Immunogenetics 40, 45-53.
13. Karlsson, L., and Peterson, P.A. (1992). The α chain gene of H-2O has an unexpected location in the major histocompatibility complex. J. Exp. Med. 176, 477-483.
14. Klein, J. (1986). Natural History of the Major Histocompatibility Complex. (New York: John Wiley and Sons).
15. Klein, J. (1989). Congenic and segregating inbred strains. In Genetic Variants and Strains of the Laboratory Mouse, M.F. Lyon and A.G. Searle, eds. (Oxford, UK: Oxford University Press), pp. 747-797.
16. Koopmann, J.-O., Hämmerling, G.J., and Momburg, F. (1997). Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9, 80-88.
17. d, and two genes reported to encode tumor-specific antigens. J. Exp. Med. 168, 1719-1739.
18. Lehner, P.J., and Cresswell, P. (1996). Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8, 59-67.
19. Livingstone, A.M., Powis, S.J., Diamond, A.G., Butcher, G.W., and Howard, J.C. (1989). A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule. J. Exp. Med. 170, 777-795.
20. Livingstone, A.M., Powis, S.J., Günther, E., Cramer, D.V., Howard, J.C., and Butcher, G.W. (1991). Cim: an MHC class II-linked allelism affecting the antigenicity of a classical class I molecule for T lymphocytes. Immunogenetics 34, 157-163.
21. Löpez, D., García-Hoyo, R., García F., López de Castro J. A. (1994). T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation. Eur. J. Immunol. 24, 1194-1199.
22. Martien van Santen, H., Woolsey, A., Rickardt, P.G., Van Kaer, L., Baas, E.J., Berns, A., Tonegawa, S., and Ploegh, H.L. (1995). Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human β2-microglobulin transgene. J. Exp. Med. 181, 787-792.
23. Marusina, K., Iyer, M., and Monaco, J.J. (1997). Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. J. Immunol. 158, 5251-5256.
24. Momburg, F., Roelse, J., Howard, J.C., Butcher, G.W., Hämmerling, G.J., and Neefjes, J.J. (1994). Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367, 648-651.
25. Nagata, T., Weiss, E.H., Abe, K., Kitagawa, K., Ando, A., Yara-Kikuti, Y., Seldin, M.F., Ozato, K., Inoko, H., and Taketo, M. (1995). Physical mapping of the retinoid X receptor B gene in mouse and human. Immunogenetics 41, 83-90.
26. Neefjes, J., Gottfried, E., Roelse, J., Grommé, M., Obst, R., Hämmerling, G.J., and Momburg, F. (1995). Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25, 1133-1136.
27. Obst, R., Armandola, E.A., Nijenhuis, M., Momburg, F., and Hämmerling, G. (1995). TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25, 2170-2176.
28. Ortmann, B., Copeman, J., Lehner, P.J., Sadasivan, B., Herberg, J.A., Grandea, A.G., Riddell, S.R., Tampé, R., Spies, T., Trowsdale, J., and Cresswell, P. (1997). A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277, 1306-1309.
29. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125, 2473-2477.
30. Pazmany, L., Rowland-Jones, S., Huet, S., Hill, A., Sutton, J., Murray, R., Brooks, J., and McMichael, A. (1992). Genetic modulation of antigen presentation by HLA-B27 molecules. J. Exp. Med. 175, 361-369.
31. a encoded antigens in T cell receptor Vβ8.1 chain transgenic mice. EMBO J. 8, 719-727.
32. Pouletty, C., Mercier, I., Glanville, L., Tomavo, N., Igoudin, L., Pouletty, P., and Buelow, R. (1994). Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay. Hum. Immunol. 40, 218-227.
33. Powis, S.J., Howard, J.C., and Butcher, G.W. (1991a). The major histocompatibility complex class II-linked cim locus controls the kinetics of intracellular transport of a classical class I molecule. J. Exp. Med. 173, 913-921.
34. Powis, S.J., Townsend, A.R., Deverson, E.V., Bastin, J., Butcher, G.W., and Howard, J.C. (1991b). Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354, 528-531.
35. Powis, S.J., Deverson, E.V., Coadwell, W.J., Ciruela, A., Huskisson, N.S., Smith, H., Butcher, G.W., and Howard, J.C. (1992). Effects of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 357, 211-215.
36. Powis, S.J., Young, L.L., Joly, E., Barker, P.J., Richardson, L., Brandt, R.P., Melief, C.J., Howard, J.C., and Butcher, G.W. (1996). The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity 4, 159-165.
37. Rammensee, H.-G., Falk, K., and Rötzschke, O. (1993). Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11, 213-244.
38. Rammensee, H.-G., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228.
39. Rowland-Jones, S.L., Powis, S.H., Sutton, J., Mockridge, I., Gotch, F.M., Murray, N., Hill, A.B., Rosenberg, W.M., Trowsdale, J., and McMichael, A.J. (1993). An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism Eur. J. Immunol. 23, 1999-2004.
40. k alleles. J. Immunol. 123, 1965-1969.
41. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
42. g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc. Natl. Acad. Sci. USA 91, 13004-13008.
43. Simmons, W.A., Taurog, J.D., Hammer, R.E., and Breban, M. (1993). Sharing of an HLA-B27-restricted H-Y antigen by rat and mouse. Immunogenetics 38, 351-358.
44. Simmons, W.A., Leong, L.Y. W., Satumtira, N., Butcher, G.W., Howard, J.C., Richardson, J.A., Slaughter, C.A., Hammer, R.E., and Taurog, J.D. (1996). Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 156, 1661-1667.
45. Simmons, W.A., Summerfield, S.G., Roopenian, D.C., Slaughter, C.A., Zuberi, A.R., Gaskell, S.J., Bordoli, R.S., Hoyes, J., Moomaw, C.R., Colbert, R.A., Leong, L.Y.-W., Butcher, G.W., Hammer, R.E., and Taurog, J.D. (1997). Novel HY peptide antigens presented by HLA-B27. J. Immunol. 159, 2750-2759.
46. Taurog, J.D., Lowen, L., Forman, J., and Hammer, R.E. (1988). HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human β2-microglobulin. J. Immunol. 141, 4020-4023.
47. Taurog, J.D., Hammer, R.E., Maika, S.D., Sams, K.L., El-Zaatari, F.A.K., Stimpson, S.A., and Schwab, J.H. (1990). HLA-B27 transgenic mice as potential models of human disease. In Transgenic Mice and Mutants in MHC Research, I.K. Egorov and C.S. David, eds. (Berlin: Springer-Verlag), pp. 268-275.
48. Taurog, J.D., Maika, S.D., Simmons, W.A., Breban, M., and Hammer, R.E. (1993). Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of expression of B27. J. Immunol. 150, 4168-4178.
49. Townsend, A., and Bodmer, H. (1989). Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7, 601-632.
50. Uematsu, Y., Fischer Lindahl, K., and Steinmetz, M. (1988). The same MHC recombinational hot spots are active in crossing-over between wild/wild and wild/inbred mouse chromosomes. Immunogenetics 27, 96-101.
51. van Endert, P.M., Tampé, R., Meyer, T.H., Tisch, R., Bach, J.-F., and McDevitt, H.O. (1994). A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1, 491-500.
52. Van Kaer, L., Ashton-Rickardt, P.G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K.L., Goldberg, A.L., Doherty, P.C., and Tonegawa, S. (1994). Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 553-541.
53. + T cells. Cell 71, 1205-1214.
54. Walter, L., Fischer, K., and Günther, E. (1996). Physical mapping of the Ring1, Ring2, Ke6, Ke4, Rxrb, Col11a2, and RT1.Hb genes in the rat major histocompatibility complex. Immunogenetics 44, 218-221.
55. York, I.A., and Rock, K.L. (1996). Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14, 369-396.